Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Infinity to Present at the 25th Annual Roth Conference



  Infinity to Present at the 25th Annual Roth Conference

25th Annual ROTH Conference

Business Wire

CAMBRIDGE, Mass. -- March 11, 2013

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the 25^th
Annual ROTH Conference on March 18, 2013, at 3:00 p.m. PT (6:00 p.m. ET) in
Laguna Nigel, CA.

A live webcast of Infinity's presentation will be accessible on the
“investors/media” section of the company's website, www.infi.com, and will be
available for 30 days following the event.

About Infinity Pharmaceuticals, Inc.

Infinity is an innovative drug discovery and development company seeking to
discover, develop and deliver to patients best-in-class medicines for diseases
with significant unmet need. Infinity combines proven scientific expertise
with a passion for developing novel small molecule drugs that target emerging
disease pathways. Infinity’s programs focused on the inhibition of
phosphoinositide-3-kinase and heat shock protein 90 are evidence of its
innovative approach to drug discovery and development. For more information on
Infinity, please refer to the company’s website at www.infi.com.

Contact:

Infinity Pharmaceuticals, Inc.
Kate Murray, 617-453-1179
Kate.Murray@infi.com
http://www.infi.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement